These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus: an analysis from the randomized evaluation in percutaneous coronary intervention linking angiomax to reduced clinical events (REPLACE)-2 trial. Gurm HS, Sarembock IJ, Kereiakes DJ, Young JJ, Harrington RA, Kleiman N, Feit F, Wolski K, Bittl JA, Wilcox R, Topol EJ, Lincoff AM. J Am Coll Cardiol; 2005 Jun 21; 45(12):1932-8. PubMed ID: 15963389 [Abstract] [Full Text] [Related]
12. Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention: results from the REPLACE-2 trial. Cohen DJ, Lincoff AM, Lavelle TA, Chen HL, Bakhai A, Berezin RH, Jackman D, Sarembock IJ, Topol EJ. J Am Coll Cardiol; 2004 Nov 02; 44(9):1792-800. PubMed ID: 15519009 [Abstract] [Full Text] [Related]
15. Lack of clopidogrel pretreatment effect on the relative efficacy of bivalirudin with provisional glycoprotein IIb/IIIa blockade compared to heparin with routine glycoprotein IIb/IIIa blockade: a REPLACE-2 substudy. Saw J, Lincoff AM, DeSmet W, Betriu A, Rutsch W, Wilcox RG, Kleiman NS, Wolski K, Topol EJ, REPLACE-2 Investigators. J Am Coll Cardiol; 2004 Sep 15; 44(6):1194-9. PubMed ID: 15364319 [Abstract] [Full Text] [Related]
16. Temporal trends, safety, and efficacy of bivalirudin in elective percutaneous coronary intervention: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium. Gurm HS, Smith DE, Chetcuti SJ, Share D, Khanal S, Riba A, Carter AJ, Lalonde T, Kline-Rogers E, O'Donnell M, O'Neill W, Safian R, Moscucci M, Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). J Interv Cardiol; 2007 Jun 15; 20(3):197-203. PubMed ID: 17524111 [Abstract] [Full Text] [Related]
17. Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial. Stone GW, Ware JH, Bertrand ME, Lincoff AM, Moses JW, Ohman EM, White HD, Feit F, Colombo A, McLaurin BT, Cox DA, Manoukian SV, Fahy M, Clayton TC, Mehran R, Pocock SJ, ACUITY Investigators. JAMA; 2007 Dec 05; 298(21):2497-506. PubMed ID: 18056903 [Abstract] [Full Text] [Related]